Nearly all shoppers (97%) taking GLP-1 inhibitor drugs like Ozempic have cut their grocery spending this year by an average of 11%, according to the State of Digital Grocery Performance Scorecard by Grocery Doppio.
The data analytics company, in partnership with Wynshop and Incisiv, reports that snacks and confectionary, prepared baked goods, and sugary beverages experienced the biggest pullback from consumers.
Survey respondents said they increased their purchases of products like lean proteins (27%) and diet foods and meal replacements (19%).
Grocers are responding to the trending weight-loss meds by altering their product assortment (77%), increasing health-oriented digital marketing (71%), and offering in-store nutritional education (43%).
Overall, grocery sales were up 3.8% year over year for the first half of 2024 to $458.5 billion. Online sales made up 13.3% of all grocery sales, according to the report, for a 2.4% year-over-year increase.